Jinghua Pharmaceutical Group Co Ltd
002349
Company Profile
Business description
Jinghua Pharmaceutical Group Co Ltd is engaged in the pharmaceutical research, development, manufacturing, and trading for active pharmaceutical ingredients, pharmaceutical intermediates, western medicines and proprietary Chinese medicine preparations. The company is also involved in the field of bio-medicine. It sells its products in China and also exports it to international countries.
Contact
No. 9 Xingtai Road
Gangzha Economic Development Zone
Jiangsu Province
Nantong226005
CHNT: +86 51385609118
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,490
Stocks News & Analysis
stocks
Navigating the ASX dividend landscape in 2026
Dividend yields are well below the 10-year average. Here’s how to navigate lower yields in 2026.
stocks
Meta stock has struggled amid AI spending concerns. Is it a buy?
Meta stock has lost ground as investors raise concern over capital expenditures and risky AI strategies.
stocks
Netflix Earnings: Strong, as expected; 2026 guidance confirms decelerating growth
We think Netflix stock is moderately overvalued.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,168.20 | 8.10 | 0.09% |
| CAC 40 | 8,069.17 | 6.59 | 0.08% |
| DAX 40 | 24,560.98 | 142.14 | -0.58% |
| Dow JONES (US) | 49,072.24 | 583.65 | 1.20% |
| FTSE 100 | 10,138.09 | 11.31 | 0.11% |
| HKSE | 26,559.01 | 26.05 | -0.10% |
| NASDAQ | 23,224.82 | 270.50 | 1.18% |
| Nikkei 225 | 53,768.80 | 994.16 | 1.88% |
| NZX 50 Index | 13,533.60 | 40.33 | -0.30% |
| S&P 500 | 6,873.77 | 76.91 | 1.13% |
| S&P/ASX 200 | 8,845.10 | 9.20 | 0.10% |
| SSE Composite Index | 4,110.86 | 6.08 | -0.15% |